SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001564590-19-001720
Filing Date
2019-02-01
Accepted
2019-02-01 17:31:13
Documents
11

Document Format Files

Seq Description Document Type Size
1 SHELF REGISTRATION STATEMENT torc-s3.htm S-3 946291
2 EX-1.2 torc-ex12_155.htm EX-1.2 295484
3 EX-4.5 torc-ex45_104.htm EX-4.5 377998
4 EX-4.6 torc-ex46_103.htm EX-4.6 428464
5 EX-5.1 torc-ex51_157.htm EX-5.1 28842
6 EX-5.2 torc-ex52_156.htm EX-5.2 10342
7 EX-23.1 torc-ex231_18.htm EX-23.1 2569
8 GRAPHIC gbhnnqu4iwko000004.jpg GRAPHIC 3633
9 GRAPHIC gbhnnqu4iwko000002.jpg GRAPHIC 3633
10 GRAPHIC gbhnnqu4iwko000001.jpg GRAPHIC 3633
11 GRAPHIC gbhnnqu4iwko000003.jpg GRAPHIC 3633
  Complete submission text file 0001564590-19-001720.txt   2111603
Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
resTORbio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-229499 | Film No.: 19560943
SIC: 2834 Pharmaceutical Preparations